Historique
Bulletin de Périodique
Drug and Alcohol Review , Vol.34, n°6 - November 2015 - Special section: Affect regulation and alcohol use - Evidence from event-level studies
Auteur(s) :
E. KUNTSCHE, Éditeur scientifique ;
R. BRUNO, Éditeur scientifique
Paru le :
01/11/2015
Article en page(s) :
569-697
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- Moody booze: Introducing the special section on affect regulation and substance use [Editorial]. Kuntsche E., Bruno R., p. 569-570.
- Negative affect variability and adolescent self-medication: The role of the peer context. Shadur J.M., Hussong A.M., Haroon M., p. 571-580.
- Daily affect variability and context-specific alcohol consumption. Mohr C.D., Arpin S., McCabe C.T., p. 581-587.
- Day-by-day variation in affect, arousal and alcohol consumption in young adults. Peacock A., Cash C., Bruno R., Ferguson S.G., p. 588-594.
- Enhancement motives moderate the relationship between high-arousal positive moods and drinking quantity: Evidence from a 22-day experience sampling study. Gautreau C., Sherry S., Battista S., Goldstein A., Stewart S., p. 595-602.
- The introduction of buprenorphine-naloxone film in opioid substitution therapy in Australia: Uptake and issues arising from changing buprenorphine formulations. Larance B., Dietze P., Ali R., Lintzeris N., White N., Jenkinson R., et al., p. 603-610.
- Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids. Peacock A., Bruno R., Cama E., Kihas I., Larance B., Lintzeris N., et al., p. 611-622.
- Injecting buprenorphine-naloxone film: Findings from an explorative qualitative study. White N., Flaherty I., Higgs P., Larance B., Nielsen S., Degenhardt L., et al., p. 623-629.
- Prevalence and correlates of neck injection among people who inject drugs in Tijuana, Mexico. Rafful C., Wagner K.D., Werb D., Gonzalez-Zuniga P.E., Verdugo S., Rangel G., et al., p. 630-636.
- Consequences of a restrictive syringe exchange policy on utilisation patterns of a syringe exchange program in Baltimore, Maryland: Implications for HIV risk. Sherman S.G., Patel S.A., Ramachandran D.V., Galai N., Chaulk P., Serio-Chapman C., et al., p. 637-644.
- Perceived barriers to utilise methadone maintenance therapy among male injection drug users in rural areas of southern Thailand. Khampang R., Assanangkornchai S., Teerawattananon Y., p. 645-653.
- A safer alternative: Cannabis substitution as harm reduction. Lau N., Sales P., Averill S., Murphy F., Sato S.-O., Murphy S., p. 654-659.
- Prevalence of illicit substance use among Arab adults in Israel: Findings from a national survey. Lawental M., Shoham M., Ron P., Azaiza F., p. 660-662.
- A systematic review of interventions for co-occurring substance use and borderline personality disorders. Lee N.K., Cameron J., Jenner L., p. 663-672.
- Associations between psychotic symptoms and substance use in young offenders. Degenhardt L., Coffey C., Hearps S., Kinner S.A., Borschmann R., Moran P., et al., p. 673-682.
- Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment-seeking adults. Young J.T., Carruthers S., Kaye S., Allsop S., Gilsenan J., Degenhardt L., et al., p. 683-693.
- Baclofen as an anti-craving agent for adolescent inhalant dependence syndrome. Kandasamy A., Jayaram N., Benegal V., p. 696-697.
- Moody booze: Introducing the special section on affect regulation and substance use [Editorial]. Kuntsche E., Bruno R., p. 569-570.
- Negative affect variability and adolescent self-medication: The role of the peer context. Shadur J.M., Hussong A.M., Haroon M., p. 571-580.
- Daily affect variability and context-specific alcohol consumption. Mohr C.D., Arpin S., McCabe C.T., p. 581-587.
- Day-by-day variation in affect, arousal and alcohol consumption in young adults. Peacock A., Cash C., Bruno R., Ferguson S.G., p. 588-594.
- Enhancement motives moderate the relationship between high-arousal positive moods and drinking quantity: Evidence from a 22-day experience sampling study. Gautreau C., Sherry S., Battista S., Goldstein A., Stewart S., p. 595-602.
- The introduction of buprenorphine-naloxone film in opioid substitution therapy in Australia: Uptake and issues arising from changing buprenorphine formulations. Larance B., Dietze P., Ali R., Lintzeris N., White N., Jenkinson R., et al., p. 603-610.
- Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids. Peacock A., Bruno R., Cama E., Kihas I., Larance B., Lintzeris N., et al., p. 611-622.
- Injecting buprenorphine-naloxone film: Findings from an explorative qualitative study. White N., Flaherty I., Higgs P., Larance B., Nielsen S., Degenhardt L., et al., p. 623-629.
- Prevalence and correlates of neck injection among people who inject drugs in Tijuana, Mexico. Rafful C., Wagner K.D., Werb D., Gonzalez-Zuniga P.E., Verdugo S., Rangel G., et al., p. 630-636.
- Consequences of a restrictive syringe exchange policy on utilisation patterns of a syringe exchange program in Baltimore, Maryland: Implications for HIV risk. Sherman S.G., Patel S.A., Ramachandran D.V., Galai N., Chaulk P., Serio-Chapman C., et al., p. 637-644.
- Perceived barriers to utilise methadone maintenance therapy among male injection drug users in rural areas of southern Thailand. Khampang R., Assanangkornchai S., Teerawattananon Y., p. 645-653.
- A safer alternative: Cannabis substitution as harm reduction. Lau N., Sales P., Averill S., Murphy F., Sato S.-O., Murphy S., p. 654-659.
- Prevalence of illicit substance use among Arab adults in Israel: Findings from a national survey. Lawental M., Shoham M., Ron P., Azaiza F., p. 660-662.
- A systematic review of interventions for co-occurring substance use and borderline personality disorders. Lee N.K., Cameron J., Jenner L., p. 663-672.
- Associations between psychotic symptoms and substance use in young offenders. Degenhardt L., Coffey C., Hearps S., Kinner S.A., Borschmann R., Moran P., et al., p. 673-682.
- Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment-seeking adults. Young J.T., Carruthers S., Kaye S., Allsop S., Gilsenan J., Degenhardt L., et al., p. 683-693.
- Baclofen as an anti-craving agent for adolescent inhalant dependence syndrome. Kandasamy A., Jayaram N., Benegal V., p. 696-697.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Dépouillements
Ajouter le résultat à votre sélection
N. LAU ;
P. SALES ;
S. AVERILL ;
F. MURPHY ;
S. O. SATO ;
S. MURPHY
|
2015
Dans Drug and Alcohol Review (Vol.34, n°6, November 2015) Article : Périodique
Dans Drug and Alcohol Review (Vol.34, n°6, November 2015) Article : Périodique
Introduction and Aims: Substitution is operationalised as a conscious choice made by users to use one drug instead of, or in conjunction with another based on: perceived safety, level of addiction potential, effectiveness in relieving symptoms, [...]
S. G. SHERMAN ;
S. A. PATEL ;
D. V. RAMACHANDRAN ;
N. GALAI ;
P. CHAULK ;
C. SERIO-CHAPMAN ;
R. M. GINDI
|
2015
Dans Drug and Alcohol Review (Vol.34, n°6, November 2015) Article : Périodique
Dans Drug and Alcohol Review (Vol.34, n°6, November 2015) Article : Périodique
Introduction and Aims: Syringe distribution policies continue to be debated in many jurisdictions throughout the USA. The Baltimore Needle and Syringe Exchange Program (NSP) operated under a 1-for-1 syringe exchange policy from its inception in [...]